Company Snapshot Home > Equity > Corporate Information > Company Snapshot
|
|
| Stock Price Details |
|
Chart |
|
|
Last Price (RS)
|
2,922.70
|
|
Change (%)
|
-25.55 (-0.87%)
|
|
Best Buy (RS)
|
0(x0)
|
|
Best Sell (RS)
|
0(x0)
|
|
Today's Range (RS)
|
2,880.25
-
2,945.85
|
|
52-Week Range (RS)
|
1,575.00
-
3,041.95
|
|
Beta (1 Year)
|
0.54
|
|
|
|
|
|
| Index Details |
| BSE 500, BSE HC, BSE Midcap |
| News |
|
Corporate Details |
| Gland Pharma Ltd gains for third straight session |
| Volumes jump at HBL Engineering Ltd counter |
| Volumes jump at Gland Pharma Ltd counter |
| Volumes jump at Vardhman Textiles Ltd counter |
| Gland Pharma appoints Deepak Sapra as CEO |
| Volumes soar at Gland Pharma Ltd counter |
| Benchmarks trade in positive terrain; realty shares jump |
| Gland Pharma rises after signing strategic CDMO pact with global pharmaceutical firm |
| Gland Pharma consolidated net profit rises 47.09% in the June 2026 quarter |
| Gland and Neuland Lab announces long term strategic CDMO partnership |
|
|
|
| Incoporation Year : 1978 |
| Chairman : SRINIVAS SADU |
| Ownership Group : MNC Associate |
| Sector : MAN |
| Industry : Pharmaceuticals - Indian - Formulations |
| Registered Office |
Gland Pharma Ltd
Sy No 143-148 150&151 Nr Gandi,
X Roads D P Pally Dundigal,
Hyderabad,
Telangana-500043 |
Phone:91-40-30510999
Fax:91-40-30510800 |
| E-Mail : investors@glandpharma.com |
| URL : http://www.glandpharma.com |
|
| Investor Returns |
|
| |
Date |
Price |
Returns (%) |
| 1Week |
04-Sep-2026 |
2932.40 |
-0.33 |
| 1Month |
11-Aug-2026 |
2924.25 |
-0.05 |
| 3Month |
11-Jun-2026 |
2305.50 |
26.77 |
| 6Month |
11-Mar-2026 |
1665.60 |
75.47 |
| 1Year |
11-Sep-2025 |
1965.55 |
48.70 |
|
|
|
|
| Mutual Funds Holding |
|
| Scheme Name |
% Holding |
Market Value (Rs Cr.) |
| HDFC Mid Cap Fund |
1.62 |
1751.05 |
| SBI Large & Midcap Fund |
2.17 |
919.59 |
| Nippon India Growth Mid Cap Fund |
1.55 |
808.02 |
| Mirae Asset Large & Midcap Fund |
1.23 |
564.15 |
| Nippon India Small Cap Fund |
0.64 |
528.80 |
|
|
|
|
| Groups : Pharmaceuticals - Indian - Formulations |
|
| Company |
Last Price |
Change (%) |
52Week High |
52Week Low |
Market Cap (Rs Cr.) |
| Torrent Pharmaceuticals Ltd |
4,975.00 |
0.95 |
5,249.95 |
3,480.00 |
189,233.01 |
| Ajanta Pharma Ltd |
3,539.95 |
0.66 |
3,796.95 |
2,335.00 |
44,234.87 |
| Rubicon Research Ltd |
1,838.35 |
2.67 |
1,896.15 |
571.00 |
30,430.56 |
| Caplin Point Laboratories Ltd |
2,754.75 |
-1.37 |
2,874.00 |
1,502.45 |
20,939.32 |
| Shilpa Medicare Ltd |
961.85 |
2.30 |
980.65 |
260.00 |
18,812.04 |
|
|
|
|